Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Spectral launches sepsis test in Italy:

This article was originally published in Clinica

Executive Summary

Spectral Diagnostics (Toronto, Canada) has begun selling its rapid sepsis testing system in Italy, through its existing local distributor, NGC Medical (Novedrate). The EAA (endotoxin activity assay) system is used to identify patients at risk of severe sepsis. Three systems have already been placed in major Italian hospitals. Spectral Diagnostics last week announced plans for a private placement to raise Can$5m (US$4m) to back launch activities for the system.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT059862

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel